|
February 7, 2015
|
TODAY'S HIGHLIGHTS |
|
Ophthalmologists must change the way they use data in order to meet the mounting challenges facing their profession, said Paul P. Lee, MD, JD, in the Drs. Henry and Frederick Sutro Memorial Lecture at the 4th Annual Glaucoma 360 New Horizons Forum. Click to read more about the challenges and opportunities |
|
A team of researchers may soon be able to catch glaucoma cases early by spotting nerve damage, said Andrew D. Huberman, PhD. Click to learn more on the research |
|
In an Ophthalmology Times video exclusive, Gary D. Novack, PhD, outlines the state of glaucoma drug therapy and where the future is headed. Click to hear about the direction of glaucoma pharmaceuticals |
|
|
We welcome your feedback!
Please send your comments to:
Mark L. Dlugoss
Group Content Director
UBM Advanstar Eyecare Group
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
